| __timestamp | Biogen Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1171036000 | 56369000000 |
| Thursday, January 1, 2015 | 1240400000 | 62786000000 |
| Friday, January 1, 2016 | 1478700000 | 62427000000 |
| Sunday, January 1, 2017 | 1630000000 | 62453000000 |
| Monday, January 1, 2018 | 1816300000 | 65724000000 |
| Tuesday, January 1, 2019 | 1955400000 | 70421000000 |
| Wednesday, January 1, 2020 | 1805200000 | 80591000000 |
| Friday, January 1, 2021 | 2109700000 | 86645000000 |
| Saturday, January 1, 2022 | 2278300000 | 100551000000 |
| Sunday, January 1, 2023 | 2533400000 | 42907000000 |
| Monday, January 1, 2024 | 0 | 115557000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Biogen Inc. and Dr. Reddy's Laboratories Limited from 2014 to 2023. Over this period, Biogen Inc. has shown a steady increase in cost efficiency, with its cost of revenue rising from approximately $1.17 billion in 2014 to $2.53 billion in 2023. This represents a growth of over 116%.
Conversely, Dr. Reddy's Laboratories Limited experienced a more volatile trajectory. Starting at around $56.37 billion in 2014, their cost of revenue peaked at $115.56 billion in 2024, despite a dip in 2023. This fluctuation highlights the challenges faced by global pharmaceutical companies in managing costs effectively. The data underscores the importance of strategic financial management in maintaining competitive advantage.
Comparing Cost of Revenue Efficiency: AstraZeneca PLC vs Biogen Inc.
Cost of Revenue: Key Insights for Zoetis Inc. and Biogen Inc.
Annual Revenue Comparison: Biogen Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Biogen Inc. and HUTCHMED (China) Limited
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored